跳至主要内容
临床试验/NCT03110042
NCT03110042已完成不适用

High Versus Low SpO2 Oxygen Therapy in Patients With Acute Heart Failure

University of Alberta1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
Change in blood oxygen saturation levels from baseline to 72 hours

研究概览

简要总结

The HILO-HF Registry is a single centre registry that will be performed to provide information on the usual baseline oxygen saturation (SpO2) in patients presenting to ED with a primary ED diagnosis of AHF

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients >40 years of age presenting to the ED with AHF
  • With or without tested BNP
  • With or without admission to hospital for treatment of HF\
  • Patients must be recruited within the first 24 hours of presenting to the ED.

排除标准

  • Patients on home oxygen
  • Patients with known prior hypercapnic failure (PaCO2>50 mmHg)
  • Primary pulmonary hypertension
  • Patients requiring urgent positive pressure ventilation or intubation or on >10 L/min oxygen

结局指标

主要结局

Change in blood oxygen saturation levels from baseline to 72 hours

时间窗: 72 hours

次要结局

  • 30-day composite clinical event (all-cause mortality, HF readmission, days alive and out of hospital)(30days)
  • Dyspnea on visual analogue scale (VAS) to 72 hours(72 hours)
  • Change in global symptoms using Patient Global Assessment (PGA) measure to 72 hours(72 hours)
  • Change in Peak Expiratory Flow(72 hours)
  • Rate of patients with Worsening Heart Failure(7 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验